IL10 and Alzheimer disease: Kim et al. demonstrated that a probiotic mixture elevated IL-10 expression while reducing Th2 cytokines, thereby restoring immune balance and alleviating AD in mice [12], suggesting that BCL-2 may exert similar effects through IL-10–mediated immune regulation, thus suggesting that BCL-2 may contribute to the improvement of AD.